On June 18, 2024, the Board of Directors of Ironwood Pharmaceuticals, Inc. appointed Sravan K. Emany, age 46, the Company?s Senior Vice President, Chief Financial Officer, to the position of Senior Vice President, Chief Operating Officer and Chief Financial Officer, effective immediately. Mr. Emany has served as the Company?s Senior Vice President, Chief Financial Officer since December 6, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.11 USD | -1.77% | -1.45% | -46.59% |
07-01 | Ironwood Pharmaceuticals, Inc.(NasdaqGS:IRWD) dropped from Russell 2000 Value-Defensive Index | CI |
07-01 | Ironwood Pharmaceuticals, Inc.(NasdaqGS:IRWD) added to Russell 2000 Dynamic Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.59% | 971M | |
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc. Appoints Sravan K. Emany as Chief Operating Officer